Treatment of myeoproliferative diseases
US7842681B2 · kind B2 · utility
47Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2007 |
| Grant date | Nov 30, 2010 |
| Priority date | — |
| Expiry date | Sep 5, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of reducing the number of platelets in mammals and preventing or treating pro-thrombotic conditions and diseases that are characterized by an excess of, or undesired activation of, platelets using inhibitors of anti-apoptotic Bcl-2 family protein members is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.